BIOMAT Database Logo BIOMAT Database Logo

Late hematogenous infection in total joint replacement. 1975

R A Brand

UI MeSH Term Description Entries
D007595 Joint Prosthesis Prostheses used to partially or totally replace a human or animal joint. (from UMDNS, 1999) Joint Prostheses,Prostheses, Joint,Prosthesis, Joint
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D006621 Hip Joint The joint that is formed by the articulation of the head of FEMUR and the ACETABULUM of the PELVIS. Acetabulofemoral Joint,Acetabulofemoral Joints,Hip Joints,Joint, Acetabulofemoral,Joint, Hip,Joints, Acetabulofemoral,Joints, Hip
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

R A Brand
Late hematogenous infection of total joint replacement.
December 1980, The Journal of bone and joint surgery. American volume,
R A Brand
Hematogenous infection in total joint replacement.
January 1978, Clinical orthopaedics and related research,
R A Brand
Late hematogenous infection: a constant threat to total joint replacement.
February 1983, Israel journal of medical sciences,
R A Brand
Hematogenous infection in total joint replacement. Recommendations for prophylactic antibiotics.
November 1979, JAMA,
R A Brand
Late hematogenous infection in total joint replacement: studies of gentamicin and bone cement in the rabbit.
January 1981, Clinical orthopaedics and related research,
R A Brand
Late hematogenous infection of first metatarsophalangeal joint replacement: a case presentation.
January 2010, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons,
R A Brand
[Late hematogenous infection of prosthetic joint].
April 2008, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca,
R A Brand
Hematogenous infection of total joint replacement. An experimental study in the rabbit.
January 1981, Acta orthopaedica Scandinavica. Supplementum,
R A Brand
Infection in total joint replacement.
September 1990, Infectious disease clinics of North America,
R A Brand
Infection and total joint replacement.
July 1977, JAMA,
Copied contents to your clipboard!